Diabetes

A recently published study assesses the use of Semaglutide, a glucagon-like peptide-1 analogue, as a treatment for patients with type 2 diabetes, in comparison with the dipeptidyl-4 inhibitor sitagliptin. With increasing prevalence of type 2 diabetes among various populations, multiple treatments have been developed in response to the demand. Research indicates that treatment of diabetes
0 Comments
Yet another benefit of maqui berry consumption has been revealed in an exploratory study in humans: extracts from the alleged superfruit lower fasting and postprandial glucose and insulin levels in prediabetics. Maqui berry is an intensely purple wild berry, growing abundantly throughout parts of Southern Chile. Its purple color comes from a high concentration of
0 Comments